CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 71.43%

Compliant submissions 5

Incompliant submissions 2

Total trials 7

My Organizations' Clinical Trials

Showing 950 of 1097 entries

View as:

Addressing Obesity in Early Care and Education Settings

Phase: N/A Priority: Normal

NCT ID: NCT04140032 Org: User:

Start: 10/01/19 End: 05/31/24 Due: 05/31/25

Tele-Exercise Platform for Plantar Wound Healing

Phase: N/A Priority: Normal

NCT ID: NCT06439667 Org: User:

Start: 04/01/25 End: 04/15/26 Due: 04/15/27

An Observational LTFU Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for ADA-SCID

Phase: N/A Priority: Normal

NCT ID: NCT04049084 Org: User:

Start: 09/26/19 End: 08/31/35 Due: 08/31/36

Pomegranate Extract and Memory

Phase: N/A Priority: Normal

NCT ID: NCT01950221 Org: User:

Start: 10/31/11 End: 10/31/15 Due: 10/31/16

Participatory Messaging in the UCLA Psychiatry Partial Hospitalization and Intensive Outpatient Programs

Phase: N/A Priority: Normal

NCT ID: NCT02708940 Org: User:

Start: 02/29/16 End: 12/31/16 Due: 12/31/17

Transcutaneous (Tragus) Vagal Nerve Stimulation for Post-op Afib

Phase: N/A Priority: Normal

NCT ID: NCT04514757 Org: User:

Start: 09/20/21 End: 04/25/24 Due: 04/25/25

Hyperalgesia in Methadone-Maintained Patients: Can it be Treated?

Phase: N/A Priority: Normal

NCT ID: NCT01210079 Org: User:

Start: 09/30/02 End: 05/31/10 Due: 05/31/11

Campus Life Study: Harnessing Generativity Among Young Adults

Phase: N/A Priority: Normal

NCT ID: NCT04207528 Org: User:

Start: 01/06/20 End: 02/10/20 Due: 02/10/21

High-Dose Moderna mRNA-1273 Booster Study for Lung Transplant Recipients

Phase: N/A Priority: Normal

NCT ID: NCT05280158 Org: User:

Start: 03/10/22 End: 02/27/23 Due: 02/27/24

Philani Home-based Nutrition Intervention Program

Phase: N/A Priority: Normal

NCT ID: NCT00995592 Org: User:

Start: 11/30/02 End: 07/31/05 Due: 07/31/06

Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW

Phase: N/A Priority: Normal

NCT ID: NCT05018611 Org: User:

Start: 01/22/22 End: 02/28/26 Due: 02/28/27

PRISM Intervention Study

Phase: N/A Priority: Normal

NCT ID: NCT03883139 Org: User:

Start: 03/01/21 End: 03/31/26 Due: 03/31/27

Pain Management in ED for Incision and Drainage of Abscess

Phase: N/A Priority: Normal

NCT ID: NCT01881997 Org: User:

Start: 06/30/11 End: 12/31/11 Due: 12/31/12

Starting Technology in At Risk Type 1 Diabetes Study

Phase: N/A Priority: Normal

NCT ID: NCT06453928 Org: User:

Start: 09/05/24 End: 06/30/27 Due: 06/30/28

Remote Ischemic Preconditioning in Subarachnoid Hemorrhage

Phase: N/A Priority: Normal

NCT ID: NCT01158508 Org: User:

Start: 04/30/10 End: 07/31/14 Due: 07/31/15

Virtual Reality-Reward Training for Anhedonia

Phase: N/A Priority: Normal

NCT ID: NCT05342077 Org: User:

Start: 09/15/22 End: 03/14/25 Due: 03/14/26

Improving the Diagnosis of Common Variable Immune Deficiency

Phase: N/A Priority: Normal

NCT ID: NCT03335605 Org: User:

Start: 05/01/19 End: 06/01/22 Due: 06/01/23

Pediatric Neural Sleeve Validation

Phase: N/A Priority: Normal

NCT ID: NCT05660096 Org: User:

Start: 01/31/24 End: 12/31/26 Due: 12/31/27

Pediatric Second Influenza Dose Portal Reminder Recall

Phase: N/A Priority: Normal

NCT ID: NCT04668417 Org: User:

Start: 12/15/20 End: 04/01/21 Due: 04/01/22

Aging Mastery Program® (AMP) Evaluation

Phase: N/A Priority: Normal

NCT ID: NCT03342729 Org: User:

Start: 05/01/17 End: 03/15/18 Due: 03/15/19

Starting Treatment With Agonist Replacement Therapies (START)

Phase: N/A Priority: Normal

NCT ID: NCT00315341 Org: User:

Start: 04/30/06 End: 08/31/10 Due: 08/31/11

Perineal Self-Acupressure

Phase: N/A Priority: Normal

NCT ID: NCT01867944 Org: User:

Start: 06/30/13 End: - Due: -

Cell Phone Technology Targeting ART Adherence and Drug Use

Phase: N/A Priority: Normal

NCT ID: NCT01884233 Org: User:

Start: 12/31/12 End: 01/31/16 Due: 01/31/17

Endothelin-1 and Cardiac Allograft Vasculopathy (CAV)

Phase: N/A Priority: Normal

NCT ID: NCT05373108 Org: User:

Start: 05/19/22 End: 02/14/23 Due: 02/14/24

Evaluating BOSCC and ELSA as Outcome Measures in the Context of a JASPER Intervention Trial

Phase: N/A Priority: Normal

NCT ID: NCT04146428 Org: User:

Start: 04/27/21 End: 08/31/25 Due: 08/31/26

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Addressing Obesity in Early Care and Education Settings	NCT04140032	University of California, Los Angeles	user2@example.com	None	2019-10-01	2024-05-31	2025-05-31	-	-	2025-07-14
Tele-Exercise Platform for Plantar Wound Healing	NCT06439667	University of California, Los Angeles	user2@example.com	None	2025-04-01	2026-04-15	2027-04-15	-	-	2025-07-14
An Observational LTFU Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for ADA-SCID	NCT04049084	University of California, Los Angeles	user2@example.com	None	2019-09-26	2035-08-31	2036-08-31	-	-	2025-07-14
Pomegranate Extract and Memory	NCT01950221	University of California, Los Angeles	user2@example.com	None	2011-10-31	2015-10-31	2016-10-31	-	-	2025-07-14
Participatory Messaging in the UCLA Psychiatry Partial Hospitalization and Intensive Outpatient Programs	NCT02708940	University of California, Los Angeles	user2@example.com	None	2016-02-29	2016-12-31	2017-12-31	-	-	2025-07-14
Transcutaneous (Tragus) Vagal Nerve Stimulation for Post-op Afib	NCT04514757	University of California, Los Angeles	user2@example.com	None	2021-09-20	2024-04-25	2025-04-25	-	-	2025-07-14
Hyperalgesia in Methadone-Maintained Patients: Can it be Treated?	NCT01210079	University of California, Los Angeles	user2@example.com	None	2002-09-30	2010-05-31	2011-05-31	-	-	2025-07-14
Campus Life Study: Harnessing Generativity Among Young Adults	NCT04207528	University of California, Los Angeles	user2@example.com	None	2020-01-06	2020-02-10	2021-02-10	-	-	2025-07-14
High-Dose Moderna mRNA-1273 Booster Study for Lung Transplant Recipients	NCT05280158	University of California, Los Angeles	user2@example.com	None	2022-03-10	2023-02-27	2024-02-27	-	-	2025-07-14
Philani Home-based Nutrition Intervention Program	NCT00995592	University of California, Los Angeles	user2@example.com	None	2002-11-30	2005-07-31	2006-07-31	-	-	2025-07-14
Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW	NCT05018611	University of California, Los Angeles	user2@example.com	None	2022-01-22	2026-02-28	2027-02-28	-	-	2025-07-14
PRISM Intervention Study	NCT03883139	University of California, Los Angeles	user2@example.com	None	2021-03-01	2026-03-31	2027-03-31	-	-	2025-07-14
Pain Management in ED for Incision and Drainage of Abscess	NCT01881997	University of California, Los Angeles	user2@example.com	None	2011-06-30	2011-12-31	2012-12-31	-	-	2025-07-14
Starting Technology in At Risk Type 1 Diabetes Study	NCT06453928	University of California, Los Angeles	user2@example.com	None	2024-09-05	2027-06-30	2028-06-30	-	-	2025-07-14
Remote Ischemic Preconditioning in Subarachnoid Hemorrhage	NCT01158508	University of California, Los Angeles	user2@example.com	None	2010-04-30	2014-07-31	2015-07-31	-	-	2025-07-14
Virtual Reality-Reward Training for Anhedonia	NCT05342077	University of California, Los Angeles	user2@example.com	None	2022-09-15	2025-03-14	2026-03-14	-	-	2025-07-14
Improving the Diagnosis of Common Variable Immune Deficiency	NCT03335605	University of California, Los Angeles	user2@example.com	None	2019-05-01	2022-06-01	2023-06-01	-	-	2025-07-14
Pediatric Neural Sleeve Validation	NCT05660096	University of California, Los Angeles	user2@example.com	None	2024-01-31	2026-12-31	2027-12-31	-	-	2025-07-14
Pediatric Second Influenza Dose Portal Reminder Recall	NCT04668417	University of California, Los Angeles	user2@example.com	None	2020-12-15	2021-04-01	2022-04-01	-	-	2025-07-14
Aging Mastery Program® (AMP) Evaluation	NCT03342729	University of California, Los Angeles	user2@example.com	None	2017-05-01	2018-03-15	2019-03-15	-	-	2025-07-14
Starting Treatment With Agonist Replacement Therapies (START)	NCT00315341	University of California, Los Angeles	user2@example.com	None	2006-04-30	2010-08-31	2011-08-31	-	-	2025-07-14
Perineal Self-Acupressure	NCT01867944	University of California, Los Angeles	user2@example.com	None	2013-06-30	-	-	-	-	2025-07-14
Cell Phone Technology Targeting ART Adherence and Drug Use	NCT01884233	University of California, Los Angeles	user2@example.com	None	2012-12-31	2016-01-31	2017-01-31	-	-	2025-07-14
Endothelin-1 and Cardiac Allograft Vasculopathy (CAV)	NCT05373108	University of California, Los Angeles	user2@example.com	None	2022-05-19	2023-02-14	2024-02-14	-	-	2025-07-14
Evaluating BOSCC and ELSA as Outcome Measures in the Context of a JASPER Intervention Trial	NCT04146428	University of California, Los Angeles	user2@example.com	None	2021-04-27	2025-08-31	2026-08-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance